Immunotherapy comes of age in lung cancer
P Khanna, N Blais, PO Gaudreau… - Clinical lung cancer, 2017 - Elsevier
Lung carcinoma is the leading cause of death by cancer worldwide. When possible, surgery
is the best treatment strategy for patients with non–small-cell lung cancer. However, even …
is the best treatment strategy for patients with non–small-cell lung cancer. However, even …
Immunotherapy Comes of Age in Lung Cancer.
P Khanna, N Blais, PO Gaudreau… - Clinical Lung …, 2016 - europepmc.org
Lung carcinoma is the leading cause of death by cancer worldwide. When possible, surgery
is the best treatment strategy for patients with non-small-cell lung cancer. However, even …
is the best treatment strategy for patients with non-small-cell lung cancer. However, even …
Immunotherapy Comes of Age in Lung Cancer
P Khanna, N Blais, PO Gaudreau… - Clinical Lung …, 2017 - infona.pl
Lung carcinoma is the leading cause of death by cancer worldwide. When possible, surgery
is the best treatment strategy for patients with non–small-cell lung cancer. However, even …
is the best treatment strategy for patients with non–small-cell lung cancer. However, even …
Immunotherapy Comes of Age in Lung Cancer
P Khanna, N Blais, PO Gaudreau… - Clinical lung …, 2017 - pubmed.ncbi.nlm.nih.gov
Lung carcinoma is the leading cause of death by cancer worldwide. When possible, surgery
is the best treatment strategy for patients with non-small-cell lung cancer. However, even …
is the best treatment strategy for patients with non-small-cell lung cancer. However, even …
Immunotherapy Comes of Age in Lung Cancer
P Khanna, N Blais, PO Gaudreau… - Clinical Lung …, 2017 - clinical-lung-cancer.com
Lung carcinoma is the leading cause of death by cancer worldwide. When possible, surgery
is the best treatment strategy for patients with non–small-cell lung cancer. However, even …
is the best treatment strategy for patients with non–small-cell lung cancer. However, even …